EDUCATION/PROFESSIONAL EXPERIENCE

EDUCATION

Graduate: Dalian Medical University (DMU); 19821987, MD

Postgraduate: Dalian Medical University (DMU); 1991-1994

Doctor: Peking University, School of Medicine; 2002-2005, PhD. (Ophthalmology)

Postdoctor: Bascom Palmer Eye Institute, School of Medicine, Miami University; 1996-1998

Postdoctor: Lion Eye Center, School of Medicine, Louisiana State University; 1998-2001

Visiting scholar: Schepens Eye Institute, School of Medicine, Harvard University; 1998.10-1999.03

Senior Visiting scholar: Wills Ophthalmic Hospital, Wills Eye Institute, School of Medicine, Pennsylvania University; 2015.01-2015.03

Senior Visiting scholar: Ophthalmic Hospital, Eye Center, Tuebingen University; 2016.08-2016.09

APPOINTMENTS

2008-present: Chairman Ophthalmology Department, Chairman Ophthalmology Teaching and Research Center, First Affiliated Hospital of DMU.

2016-present: Visiting Professor, Ophthalmic Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Institute of Ophthalmology and Optometry Medical College of Shandong University of Traditional Chinese Medicine.

2011-present: Doctoral Supervisor, Ophthalmology, Secretary of Surgery Branch, First Affiliated Hospital, DMU.

2010-present: Secretary General Surgery Branch, First Affiliated Hospital, DMU.

2004 -2008: Vice chairman, Ophthalmology Department and Ophthalmology Teaching and Research Center, Secretary of the Party Branch, Ophthalmology Department, First Affiliated Hospital of DMU.

2001-present: Supervisor of postgraduate degree students, Ophthalmology Department, First Affiliated Hospital of DMU.

2001-present: Professor, Chief Physician, Ophthalmology Department, First Affiliated Hospital of DMU.

1996-2001: Associate Professor, Ophthalmology Department, First Affiliated Hospital of DMU.

1993-1996: Attending doctor, Ophthalmology Department, First Affiliated Hospital of DMU.

1987-1993: Residence and Postdoctor, Ophthalmology Department, First Affiliated Hospital of DMU.

PARTICIPATION IN THE ACADEMIC COMMUNITY

1996-present: Member, Association for Research in Vision and Ophthalmology（ARVO）

1997-present: Member, American Academic of Ophthalmology

1999-present: Member, International Society for Eye Research（ISER）

2008-present: Committee Member, Ophthalmic Branch of Chinese Medical Doctor Association.

2016-present: Committee Member, Ophthalmic Branch of the Chinese Medical Association.

2011-present: Committee Member, Fundus Disease Society of China.

2016-present: Deputy Leader, The Subspecialty Groups of Ophthalmic, The Society of Pediatrics, Chinese Medical Association.

2017-present:Vice Chairman, National Eye Health, Medical Research Association, Ophthalmology Branch.

2017-present:Vice Chairman, Society for Neuroscience and Neurology, Chinese Research Hospital Association, SNN/CRHA.

2016-present: Committee Member, Retinal Vascular Disease Group, Department of Ophthalmology, Medical and Health Communications Association of the Two Sides of the Taiwan Straits.

2016-present: Committee Member, Macular Group, Department of Ophthalmology, Medical and Health Communications Association of the Two Sides of the Taiwan Straits.

2015-present: Committee Member, Department of Ophthalmology, Medical and Health Communications Association of the Two Sides of the Taiwan Straits.

2015-present: Committee Member, Department of Ophthalmology, Chinese Medical Doctor Association, Physician Branch of the Fundus Disease Specialized Committee.

2013-present: Committee Member, Advisory Committee of Experts on the Chinese Fundus Diseases.

2016-present: Committee Member, Elderly Health Care Branch of the Ophthalmic Group Specialist, Chinese Medical Association.

2016-present: Member, European and American Students Association and Chinese Students Association.

2016-present: Member, Physicians and Surgeons of the Ophthalmic Branch, European and American Association.

2003-2008: Youth Committee Member, Chinese Ophthalmologic Association.

2016-present: Member, China-Russia Ophthalmic branch.

2016-present: Member, Department of Vitreous and Retina, the Medical Society of the Sea.

2013-present: Committee Member, National Ophthalmology Quality Control Center.

2016-present: Chairman Designate Elect, Ophthalmologic Association of Liaoning Province.

2018-present: Leading Talent for Science and Technology Innovation (Specially Appointed Professor of Liaoning).

2012-2016: Vice Chairman, Ophthalmologic Association of Liaoning Province.

2013-present: Vice Chairman, The Center for Prevention of Blindness of Liaoning Province.

2014-present: Vice Chairman, Ophthalmology Quality Control Center of Liaoning Province.

2014-present: Chairman, Ocular Trauma Society of Liaoning Province.

2010-present: Vice Chairman, Ophthalmological Branch of Traditional Chinese Medicine of Liaoning Province.

2008-present: Vice Chairman, Society for the Rehabilitation of Ocular Trauma of Liaoning Province.

2015-present: Chairman, Key College of Department of Ophthalmology of Liaoning Province.

2011-present: Chairman, Dalian Branch Center for Diabetic Eye Disease Diagnosis and Treatment Center of Liaoning Province.

2008-present: Chairman, National Vision Optical Excimer (Dalian).

2008-present: Chairman Elect, Ophthalmologic Association of Dalian.

2011-present: Member, the Third Medical Accident Technical Identification Expert Library, Liaoning Provincial Medical Association.

2008-2011: Committee Permanent Member, Ophthalmologic Association of Liaoning Province.

2016-present: Committee Member, Traditional Chinese Medicine, Liaoning Provincial Institute.

2012-present: Chairman, Ophthalmology Quality Control Center of Dalian.

2013-present: Chairman Designate Elect, Ophthalmology Association of Dalian.

2008-2013: Vice Chairman, Ophthalmologic Association of Dalian.

2005-present: Chairman, First Level Key Discipline of Dalian.

2010-present: Member, Medical Accident Technical Identification Expert Database, Dalian Medical Association.

2011-present: Basic Medical Insurance Medicine Specialist, Dalian.

2018-present:Editorial Member,《Chinese Journal of Ophthalmology》

2018-present:Editorial Member,《Chinese Journal of Experimental Ophthalmology》

2013-present: Associate Editor,《Chinese Journal of Community Medicine》

2014-present: Editorial Member,《Medicine and Philosophy》

2014-present: Editorial Member,《Journal of Dalian Medical University》

2012-present: Editorial Member,《Chinese Journal of Clinicians》

2011-present: Editorial Member,《Chinese Journal of Ocular Fundus Disease》

2010-present: Editorial Member,《Chinese Journal of Postgraduates of Medicine》

2008-present: Editorial Member,《Medical Journal of Liaoning》

2002-present: Editorial Member,《Eye Science》

2016-present: Editorial Member,《International journal of ophthalmology》

2010-present: Editorial Member of Communication,《Chinese Journal of Experimental Ophthalmology》

2012-present: Reviewer,《Current Eye Research》

2012-present: Reviewer,《Experimental Eye Research》

2010-present: Reviewer,《Molecular Vision》

2010-present: Reviewer,《Retina》

2007-present: Reviewer,《Journal of Ocular Pharmacology and Therapeutics》

2005-present: Reviewer,《Chinese Journal of Ophthalmology》

2004-present: Reviewer,《AJO》

2003-present: Reviewer,《Cornea》

2002-present: Reviewer,《British Journal of Ophthalmology》

2002-present: Committee Member and Reviewer, National Natural Science Foundation of China.

2002-present: Committee Member and Reviewer, General Program of National Natural Science Foundation of China.

2003-present: Committee Member and Reviewer, Major Program of National Natural Science Foundation of China.

2003-present: Committee Member and Reviewer, The State Key Program of National Natural Science Foundation of China.

2002-present: Committee Member and Reviewer, National Natural Science Funds of the State Council for Distinguished Young Scholar.

2002-present: Committee Member and reviewer, National Natural Science Funds of the State Council for Outstanding Young Scholar.

2007-present: Committee Member and Reviewer, Major Overseas Cooperation Projects of National Natural Science Foundation of China.

2006-present: Committee Member and Reviewer, Overseas Cooperation Projects of National Natural Science Foundation of China.

2005-present: Committee Member and Reviewer, Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry.

2011-present: Committee Member and Reviewer,Ministry of Science and Technology Achievements Appraisal Committee.

2010-present: Committee Member and Reviewer,National Ministry of Science and Technology Major Special Program.

2010-present: Committee Member and Reviewer,National Ministry of Science and Technology Major Program.

2011-present: Committee Member, National Excellent Doctor Evaluation.

2003- present: Committee Member and Reviewer,Natural Science Foundation of Liaoning Province.

2004-present: Committee Member and Reviewer,Education Reform Project Foundation of Liaoning Province.

Etc…

PUBLICATION

1.Tang F; Ma X*. Optical Coherence Tomography Predictors Of Short-term Visual Acuity In Eyes With Macular Edema Secondary To Retinal Vein Occlusion Treated With Intravitreal Conbercept, Retina.

2.Chen WJ; Ma X*. Valproic acid's effects on visual acuity in retinitis pigmentosa: a systemic review and Meta-analysis., Int J Ophthalmol, 2019.1.18, 12(1): 129~134.

3.Shifeng Fang,Xiang Ma, Suping Guo, Jianmin Lu. MicroRNA-126 inhibits the cell proliferation and invasion in diabetic retinitis model via targeting IRS-1.Oncol Lett.

2. Shaoyi Liu, Xiaofang Du,Xiang Ma, Jianlian Gu, Jianmin Lu, Lusheng Ma. Low plasma levels of brain derived neurotrophic factor are potential risk factors for diabetic retinopathy in Chinese type 2 diabetic patients. Mol Cell Endocrinol, 2016; 420: 152-158.

3. Zhuo Ye, Yan-Li Ji,Xiang Ma, Jian-Guo Wen, Wei Wei, Shu-Man Huang. Pharmacokinetics and distributions of bevacizumab by intravitreal injection of Bevacizumab-PLGA Microspheres in Rabbits.Int J Ophthalmol, 2015; 8(4): 653-658.

4. Y Li,X Ma. Research progress of induced pluripotent stem cells differentiating into retinal pigment epithelial cells. Chinese Journal of Ocular Fundus Disease, 2015; 31(2):212-214.

5. XH Qin, JM Lu, X Ma. The protective effect of Notch signal on the apoptosis of human retinal vascular endothelial cells induced by high glucose. Recent Advances in Ophthalmology, 2015; 35(9):6-10.

6. FX Kong, ZH Sun, X Ma. Abnormal bone tissue in intermittent external strabismus with external rectus. Chinese Journal of Practical Ophthalmology, 2015; 33(2): 208-208.

7. SF Fang, YY L, X Ma. A case of palmoplantar pustulosis with eyelid and conjunctivitis. Chinese Journal of Experimental Ophthalmology, 2015; 33(7): 659-659.

8. QF Qi, X Ma. Clinical observation of triamcinolone acetonide assist vitrectomy. Chinese Journal of ocular trauma, 2014; 36(12): 903-907.

9. L Cui, X Ma. Animal study on transplantation of human umbilical vein endothelial cells for corneal endothelial decompensation.Int Eye Sci, 2014; 14(6): 1010-1012.

10. JM Lu, X Ma. The role of dendritic cells in corneal-associated diseases.Chin J Optom Opthalmol Vis Sci, 2013; 15(7): 445-448.

11. Mingfei Ni, Xiang Ma, Zhijin Lang. Research on the visual pathway of central nervous system of the glaucoma patients by combination of diffusion tensor imaging and proton density weighted imaging.Chinese Journal of Ocular Fundus Disease. 2012; 28（7）: 355-358.

12. Jianmin Lu, Xiang Ma. Posterior scleritis: a wrong or missed diagnosis but treatable ocular disease.Chinese Journal of Experimental Ophthalmology. 2012; 30（8）: 757-760.

13. Zhuo Ye, Yanli Ji,Xiang Ma. Progression of the molucular genetics and treatment of X linked juvenile retinoschisis.Chinese Journal of Experimental Ophthalmology.2012; 30:94-96.

14. Lin Liu, Xiang Ma, Zhuo Ye. Research on the distribution and its side effects of the Avastin after injection in the rabbit anterior chamber.Chinese Journal of Experimental Ophthalmology. 2012; 30:94-96.

15. Jianmin Lu, Xiuli Lu, Xiang Ma. Treatment of rabbit limbal stem cell deficiency by rabbit bone marrow mesenchymal stem cells and human amniotic epithelial cells.Chinese Journal of Experimental Ophthalmology. 2011; 9:786-792.

16. Xiang Ma, Xiaoxin Li, Guiyang Zhao. Research on the relationship of gene mutation type and clinical phenotype in XLRS1 gene. Chinese Journal of Experimental Ophthalmology. 2011; 4: 367-372.

17. Jun Li, Xiang Ma. In vitro inhibition of the amniotic membrane culture fluid on the expression of the VEGF of the corneal epithelium. International Journal of Ophthalmology. 2010; 4: 643-645.

18. Liru Wang, Xiang Ma. Development of the MRI change in the visual pathway of the glaucoma patients. International Journal of Ophthalmology. 2010; 1: 93-96.

19. Jianmin Lu, Xiang Ma. The application research of the bone marrow mesenchymal stem cells in Ophthalmology. International Journal of Ophthalmology. 2009; 10: 1952-1956.

20. Lin Liu, Xiang Ma. Analysis of the influencing factors on the corneal endothelium. International Journal of Ophthalmology. 2009; 9: 121-123.

21. Yiping Jiang, Xiang Ma. Case control study on the risk factors of the age-related macular degeneration.Chinese Journal of Practical Ophthalmology. 2008；26：333-336.

22. X Ma, XX Li, and LH. Wang. Identification of the new mutations of the XLRS1 gene in Chinese patients with X linked juvenile retinoschisis. Japanese Journal of Ophthalmology.2008; 52(1):48-51.

23. XX Li, X Ma. Clinical features of X linked juvenile retinoschisis in Chinese families associated with novel mutations in the RS1 gene. Molecular Vision. 2007; 13:804-12.

24. Xiang Ma, Xiaoxin Li, Lihua Wang. Analysis of the gene mutation of the XLRS.Chinese Journal of Ocular Fundus Disease. 2006; 22: 77-81.

25. Xiang Ma, Chunxia Ni,Haydee Bazan,Hongcheng Sun. Experimental research on the delayed healing of the corneal epithelial wound induced byPlatelet-activating factor (PAF). Chinese Journal of Ophthalmology. 2004; 40(3):151-155.

26. Xiang Ma,Haydee Bazan,Jun Li. Experimental research on the corneal neovascularization suppressed by human amniotic membranes culture fluid. Chinese Journal of Ophthalmology. 2003; 39(12):753-6.

27. Xiang Ma, Guiyang Zhao, Jian Shen, Xiaoqin Yu. Experimental research on the apoptosis of the corneal stromal cells suppressed by human amniotic membranes culture fluid. Chinese Ophthalmic Research. 2003; 21(4):383-387.

28. X.Ma,J.Li.Corneal neovascularization suppressed byTIMP2 release from human amniotic membranes. Eye Science.2005; 21(1):66-71.

29. X.Ma, P Ottino,and NG. Bazan. PAF Induces Corneal Neovascularization and Upregulates VEGF Expression in Endothelial Cells Investigative Ophthalmology & Visual Science 2004; 45: 2915-2921.

30. Chandrase G, X Ma, Bazan HE. Delay of corneal wound healing and induction of keratocyte apoptosis by PAF.Invest Ophthal & Vis Science2002; 43:1422-8.

31. X.Ma, NG.Bazan, and HEP.Bazan. Expression of the PAF receptor results in enhanced ultraviolet radiation-induced apoptosis in human and rabbit corneal epithelial cells. Current Eye Research 2001; 23(5):326-35.

32. X.Ma, W.J.Lukiw, H.E.Bazan PAF activated NF-κB in human corneal epithelial cells causes inhibition of apoptosis. Invest Ophthal & Vis Science 2001; 42: 812.

33. X.Ma, and HEP. Bazan. Increased platelet-activating factor (PAF) receptor gene expression by corneal epithelial wound healing: Up-regulation by PAF and growth factors. Investigative Ophthalmology & Visual Science2000; 41:1696-1702.

34. SCG.Tseng, D.Li, and X.Ma. Suppression of Transforming Growth Factor-beta isoforms, TGF-b receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. Journal of Cellular Physiology 1999; 179:325-335.

35. J.Hurst, X.Ma, and HEP.Bazan. PAF binding to a single receptor in corneal epithelium plasma membrane. Investigative Ophthalmology & Visual Science1999; 40: 790-795.

36. HEP. Bazan and X Ma. Platelet-activating factor (PAF) enhances apoptosis induced by ultraviolet radiation in corneal epithelial cell through cytochrome c-caspase activation Investigative Ophthalmology & Visual Science IOVS 2000, 41(4), S190.

37. X Ma, NG. Bazan, and HEP. Bazan. Platelet-activating factor (PAF) induces in vivo angiogenesis in cornea and up-regulates vascular endothelial growth factor (VEGF) expression in vascular endothelial cells. Investigative Ophthalmology & Visual Science IOVS 2000, 41(4), S176.

38. X Ma, and HEP.Bazan. Up-regulation of platelet-activating factor (PAF) receptor gene expression during corneal wound healing Twelfth Annual Neuroscience center Retreat of The Louisiana State University. Feb.5, 2000, S23.

39. X.Ma, NG. Bazan, and HEP. Bazan A new corneal angiogenic factor: Platelet-Activating Factor (PAF) and its potentials mechanism International Society for Eye Research (ISER), Oct.15, 2000 Santa Fe, New Mexico.

40. X Ma and HEP. Bazan. Platelet-activating factor (PAF) receptor expression is up-regulated during corneal wound healing. Investigative Ophthalmology & Visual Science IOVS 1999, 40(4), S102.

41. HEP. Bazan,X Ma, and G.Chandrasekher. Platelet-activating factor (PAF) delays epithelial wound healing in the cornea and cause apoptosis of injured epithelial cells.Investigative Ophthalmology & Visual Science IOVS 1999, S789.

42. X Ma, and HEP. Bazan. Hepatocyte growth factor, keratinocyte growth factor and transforming growth factors upregulate PAF receptor expression in rabbit corneal cells.KEYSTONE SYMPOSIA: Ocular Cell and Molecular Biology, Keystone, Colorado Feb. 1999.

43. HEP. Bazan, G.Chandrasekher, and X Ma. PAF modulates corneal epithelial wound healing. Double labelling techniques KEYSTONE SYMPOSIA: Ocular Cell and Molecular Biology, Keystone, Colorado Feb. 1999.

44. SCG.Tseng, D.Li, andX Ma. Down-regulation of TGF-b1, b2, b3, and TGF-b receptor II expression in human corneal fibroblasts by amniotic membrane. Investigative Ophthalmology & Visual Science IOVS 1998, 39(4), S428.

45. X Ma, and SCG. Tseng. Transplantation of amniotic membrane for ocular surface reconstruction in patients with limbal deficiency. American Academic of Ophthalmology AAO, 1998, S149.

46. X Ma, and HEP. Bazan. TGF-b1, b2, b3 up-regulate PAF receptor expression in rabbit corneal cells.Sixth International Congress on Platelet-Activating Factor and Related Lipid Mediators1998, S105.

47. X Ma, and HEP.Bazan. The expression of platelet-activating factor receptor (PAF-R) in human corneal epithelium and its modulation. Investigative Ophthalmology & Visual Science IOVS 1998, S39 (4), 87.

48. X Ma, RW. Beuerman, and HEP.Bazan. Immunoloalization and immunoblot analysis of Na-K channel and Na-K ATPasa in rat corneal nerve.Tenth Annual Neuroscience center Retreat of The Louisiana State University. Feb.28, 1998, S25.

49. D.Li,X Ma and SCG. Tseng. Down-regulation of TGF-beta 1, beta 2, beta 3, and TGF-beta receptor expression in human corneal and limbal fibroblasts by amniotic membrane. Molecular Biology of the Cell, 1997; 8: S1652.

50. X Ma, D.Li, SCG.Tseng. Cytokine expression by human corneal and limbal fibroblasts is modulated by amniotic membrane. Investigative Ophthalmology & Visual Science IOVS 1997; 38(4), S512.

51. M.Wang, T.Gray, P.Prabhasawat, X Ma, W.Culbertson, R.Forster, K.Hanna, E.Hernandez, F-Y Ding, and SCG.Tseng. Corneal haze is reduced by amniotic membrane matrix in excimer laser photoablation in rabbits Investigative Ophthalmology & Visual Science IOVS 1997, 38(4), S405.

52. F-J.Zhang, John Doane, X.Ma, Y-L.Liu, Y-X. Wang, and P. Jiu. A preliminary clinical report of laser in situ keratomileusis for correction of high myopia. Chinese Journal of Practical Ophthalmology1997;9:541-548.

53. S.Chang, X.Ma, and Z-J.Lang. The CT-diagnosis of malignant choroidal melanomas Chinese Tumor1996; 3:280.

54. X Ma, Y.X.Hao, Y.N.Xue, JG.Huang. The experimental study on the suppression of PVR by elemene and dexamethasone. Chinese Journal of Practical Ophthalmology1996; 9: 541-46.

55. X Ma, and H-C.Sung. Removing the non-metal foreign body in deep cornea anterior chamber using 2% methycellulose Journal of Injuries and Occupational Diseases of the Eye 1991;1:19.

56. H-C.Sung, S-P.Guo, and X Ma. Penetrating keratoplasty combined with Sclerctoiridectomy Chinese Journal of Practical Ophthalmology 1990; 4:289.

57. Etc…

RESEARCH PROJECTS/GRANTS

2016 PI, Education Science Planning Project of Liaoning Province

2016 PI, Special Fund for Translational Medicine, Dalian Medical University

2013 PI, Dalian Science and Technology Project (Number: 2013E15SF162)

2012 PI, National Natural Science Foundation of China (Number:81271022)

2012 PI, Natural Science Foundation of Liaoning Province(Number:201202044)

2011 PI, Ocular Stem Cell Research Foundation Dalian

2009 PI, National Natural Science Foundation of China(Number:30973263)

2004 PI, National Natural Science Foundation of China (Number:30471859)

2002 PI, National Natural Science Foundation of China (Number:30170997)

2004 PI, Natural Science Foundation of Liaoning Province (Number:20042143)

2002 PI, Natural Science Foundation of Liaoning Province(Number:2001101055)

2001 PI, Dalian Science and Technology Key Project(Number:D-20011210)

1999: Fight for Sight Fund of USA (Number: PD98020)

ADMISSION PLAN/REQUIREMENTS

1.Good morality, good conduct, self-cultivation and a firm belief

2.Have a strong interest in knowledge of Ophthalmology

3.Good English spoken and reading ability

4.Have enough and correct understanding for the future medicine

5.Have the spirit of medicine assiduously

6.Have the spirit of open-minded learning, continuous progress, and constantly accumulate the experience

7.Have a good medical ethics knowledge.